2024 KIAS: Tumor Heterogeneity and Drug Resistance Session 2, Part1

Session Two: Integrating Genomics & Signaling in Tumor Drug Response, featuring:

Paul Mischel
Stanford University
"Extrachromosomal DNA (ecDNA): Cancer’s dynamic circular genome"

Rameen Beroukhim
Dana-Farber Cancer Institute and Harvard Medical School
"Effects of positive and negative selection on cancer genomes"